ArticleBreast cancer research and treatment2025

Comment on "Baseline hemoglobin and neutrophil-to-lymphocyte ratio as prognostic biomarkers in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan in second line and beyond: a real-world analysis".

S Dhanya Dedeepya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.